Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | PSMB5 | P28074 | 5/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | POLB | P06746 | 2/20 | 0.31 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.31 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
| ▸ | SRC | P12931 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25801881 | 0.94 | L3MBTL1 (0.33) | L3MBTL1KMT2ARAB9ASMN1; SMN2S1PR1 | |
| SCHEMBL25801972 | 0.94 | MEN1 (0.35) | L3MBTL1PSMB5KMT2APOLBADRB2 | |
| SCHEMBL25801750 | 0.93 | TRPA1 (0.37) | SMN1; SMN2MAPT | |
| SCHEMBL23588069 | 0.91 | L3MBTL1 (0.33) | L3MBTL1PSMB5KMT2APOLBADRB2 | |
| SCHEMBL25801790 | 0.88 | MEN1 (0.34) | L3MBTL1KMT2ASRCMEN1 | |
| SCHEMBL25801813 | 0.87 | SRC (0.33) | KMT2AS1PR1S1PR3SRCMEN1 | |
| SCHEMBL25801838 | 0.87 | SIRT2 (0.33) | SMN1; SMN2SRCMAPT | |
| SCHEMBL25801774 | 0.86 | KMT2A (0.36) | KMT2AHPGDRAB9ASMN1; SMN2SRC | |
| SCHEMBL23588272 | 0.86 | L3MBTL1 (0.33) | L3MBTL1KMT2ARAB9ASMN1; SMN2S1PR1 | |
| SCHEMBL25801926 | 0.85 | SRC (0.34) | SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230219907-A1 | CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES | SITRYX THERAPEUTICS LIMITED (GB) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230219907-A1 | CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES | CPA2, RO60, C5AR1 | L3MBTL1 3425/4885PSMB5 1688/4885KMT2A 3125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.